[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.83.210. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1984

Failure of Lysine in Frequently Recurrent Herpes Simplex InfectionTreatment and Prophylaxis

Author Affiliations

From the Department of Dermatology, University of Miami (Fla) School of Medicine. Dr DiGiovanna is now with the Dermatology Branch, National Institutes of Health, Bethesda, Md.

Arch Dermatol. 1984;120(1):48-51. doi:10.1001/archderm.1984.01650370054010
Abstract

• Lysine has been claimed to be effective in the treatment and prevention of episodes of recurrent herpes simplex (HS) infection. We carried out a double-blind, placebo-controlled trial of oral lysine hydrochloride therapy (400 mg, three times a day) in a group of 21 patients in good general health with a history of frequently recurring infection. Using our measures of episode frequency, duration, and severity, we were unable to detect any substantial benefit of lysine therapy either as a treatment for episodes in progress or as a prophylactic drug for the prevention of recurrences. We conclude that it is unlikely that lysine improves frequently recurrent HS infections in the majority of patients.

(Arch Dermatol 1984;120:48-51)

×